Similar diabetes outcomes seen with weekly dulaglutide, daily liraglutide

07/16/2014 | Healio (free registration)

A study in The Lancet found diabetes patients on once-weekly dulaglutide treatment showed A1C and hypoglycemia improvements similar to those who received once-daily liraglutide. The differences in reported adverse events were also nonsignificant in both groups, researchers noted.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC